Harvard Bioscience (HBIO) Reports Q4 EPS of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.60 -3.37%
EPS Growth %: -800.0%
Financial Fact:
Interest expense: -142K
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: -800.0%
Financial Fact:
Interest expense: -142K
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, versus ($0.02) reported last year. Revenue for the quarter came in at $33.1 million, versus $31 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Inspire Medical Systems (INSP) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 Guidance
- National Presto Indust. (NPK) Reports Q3 EPS of $2.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
